Central noradrenaline transporter availability in highly obese, non-depressed individuals
Swen Hesse, Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Julia Luthardt(Leipzig University), Katrin Arélin(Max Planck Institute for Human Cognitive and Brain Sciences), G Reissig(Leipzig University), Donald Lobsien(Defense Information Systems Agency), Mohammed K. Hankir(IFB Adiposity Diseases), Sabrina Baldofski(IFB Adiposity Diseases), Michael Stümvoll(IFB Adiposity Diseases), Mathias Faßhauer(Leipzig University), Marianne Patt, Franziska Zientek(Leipzig University), Georg‐Alexander Becker(Leipzig University), Matthias Blüher(Leipzig University), Yu‐Shin Ding(New York University), Philipp Meyer(Leipzig University), Wiebke Fenske(IFB Adiposity Diseases), Ulrich Müller(University of Cambridge), Anja Hilbert(German Centre for Cardiovascular Research), Anke Bresch(Leipzig University), Michael Rullmann(Max Planck Institute for Human Cognitive and Brain Sciences)
Cited by 110
Related Papers
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Metabolically Healthy Obesity
|Endocrine Reviews|2020|995
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823